A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants

Clinical trial NCT05667779 · COMPLETED

Trial details

NCT number: NCT05667779
Sponsor: QurAlis Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2022-12-22
Primary completion: 2023-12-27
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.